Related Experiment Video
Updated: May 26, 2025
A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Vancomycin dosing design method considering risk factors for nephrotoxicity
Yoshihiko Matsuki1,2, Yutaro Kozima3, Megumi Yanagi3
1Center for Promotion of Pharmaceutical Education & Research, Teiyo University, Tokyo, Japan. matsuki.yoshihiko.zt@teikyo-u.ac.jp.
Background:
Vancomycin (VCM) induces nephrotoxicity in a dose-dependent manner, and patients with risk factors for nephrotoxicity have been reported to develop nephrotoxicity even within the effective concentration range. In the present study, we investigated measures to set an appropriate AUCss for each case by assessing the risk of developing nephrotoxicity using logistic regression curves, separating patients into a High-risk group with risk factors associated with nephrotoxicity when VCM is used and a Low-risk group without risk factors.
Methods:
A multivariate logistic regression analysis was used to identify risk factors for nephrotoxicity. The AUCss threshold was selected by a CART analysis and ROC curves, and a logistic regression analysis was used to examine the relationship between AUCss and the probability of developing nephrotoxicity.
Results And Discussion:
The incidence of nephrotoxicity was 31.7% (33/104) in the High-risk group and 13.0% (14/108) in the Low-risk group, and was significantly higher in the former (p = 0.001). The AUCss threshold was set at 575 mg·h/L for the High-risk group and 650 mg·h/L for the Low-risk group. The probability of developing nephrotoxicity in the High-risk group (104 patients) was high: AUCss 400 mg·h/L (16.8%), 500 mg·h/L (23.3%), and 575 mg·h/L (29.3%). The target concentration range was newly set at 400 ≤ AUCss < 500, suggesting that the target AUCss needs to be considered for each patient based on the balance between therapeutic efficacy and the prevention of adverse effects. The probability of developing nephrotoxicity in the Low-risk group (108 patients) was AUCss 500 mg·h/L (4.7%), 575 mg·h/L (8.4%), and 650 mg·h/L (14.6%). Since the Low-risk group has a high safety profile, the target concentration range was newly set at 400 ≤ AUCss < 650, suggesting the safe administration of the drug up to AUCss 650 mg·h/L while aiming for AUCss 600 mg·h/L from the initial dose design.
Conclusion:
In the present study, the risk of nephrotoxicity for each AUCss was quantitatively analyzed using logistic regression curves for the High- and Low-risk groups. This allowed for the proposal of strategic individual target concentrations based on the balance between risk and benefit.
Insights
This study establishes individualized vancomycin (VCM) AUCss targets to minimize nephrotoxicity risk. High-risk patients benefit from lower AUCss targets, while low-risk patients can safely receive higher concentrations.
Area of Science:
- Pharmacology
- Nephrology
- Clinical Pharmacy
Background:
- Vancomycin (VCM) nephrotoxicity is a significant concern, occurring in a dose-dependent manner.
- Patients with pre-existing risk factors are susceptible to VCM-induced kidney damage even within therapeutic ranges.
- Individualized dosing strategies are crucial for optimizing VCM therapy and mitigating adverse events.
Purpose of the Study:
- To assess the risk of VCM-induced nephrotoxicity using logistic regression curves.
- To differentiate between high-risk and low-risk patient groups based on nephrotoxicity risk factors.
- To establish appropriate AUCss (area under the concentration-time curve) thresholds for each patient group.
Main Methods:
- Multivariate logistic regression analysis identified key risk factors for nephrotoxicity.
- CART analysis and ROC curves determined the optimal AUCss thresholds.
- Logistic regression examined the relationship between AUCss and nephrotoxicity probability in distinct risk groups.
Main Results:
- Nephrotoxicity incidence was significantly higher in the high-risk group (31.7%) compared to the low-risk group (13.0%).
- Recommended AUCss thresholds were 575 mg·h/L for high-risk and 650 mg·h/L for low-risk patients.
- Target concentration ranges were proposed: 400–500 mg·h/L for high-risk and 400–650 mg·h/L for low-risk patients.
Conclusions:
- Quantitative analysis of AUCss-specific nephrotoxicity risk was performed for both high- and low-risk groups.
- Individualized target AUCss concentrations are proposed to balance therapeutic efficacy and nephrotoxicity prevention.
- This approach supports strategic VCM dosing tailored to individual patient risk profiles.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
06:38Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Related Concept Videos
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:15Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
01:21Factors Affecting Drug Response: Overview
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
01:19Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...